Varithena FDA Approval History
FDA Approved: Yes (First approved November 25, 2013)
Brand name: Varithena
Generic name: polidocanol
Dosage form: Injectable Foam
Company: BTG plc
Treatment for: Varicose Veins
Varithena (polidocanol) injectable foam is a sclerosing agent indicated for the treatment of varicose veins.
Development Timeline for Varithena
|Nov 26, 2013||FDA Approves Varithena (Polidocanol Injectable Foam) for the Treatment of Patients with Varicose Veins|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.